Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Aknicare Fast Creamgel** is a topical, oil-free cream-gel medical device from General Topics for mild to moderate acne vulgaris, including comedones, papules, pustules, and excess sebum. The product contains triethyl citrate, ethyl linoleate, honokiol, and GT peptide-10. The registered trial description calling the intervention \"spot cream\" specifies this same four-ingredient composition, supporting its identification as Aknicare Fast Creamgel rather than Aknicare Cream, which has a different formulation. ([synchroline.com](https://www.synchroline.com/en/prodotti/aknicare-en/aknicare-fast-creamgel/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aknicare Fast Creamgel.